Equity · Healthcare
INCY
NASDAQIncyte (INCY)
The line runs 108.59 USD on 13 October through 121.88 USD on 9 November, on a scale from 105 to 125. Days the market did not trade hold the previous close, flat.
- Market cap
- 24.8B USD
- P/E (TTM)
- 64.8
- Revenue, year to Dec 2025
- 5.1B USD
- EPS, diluted, year to Dec 2025
- 6.41 USD
- 52-week range
- 90 USD – 122.92 USD
- Avg volume
- 169.7K
- Mentions, 30 days
- 1
as of Nov 9, 2026
Have Incyte (INCY) insiders bought or sold shares recently?
In the 90 days to 10 Nov 2026, Incyte insiders reported 5 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 19 Feb 2026, show no open-market purchase.
Form 4, 90 days to 10 Nov 2026, newest reported trade 3 Nov 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 03 Nov 2026 | Tray ThomasPrincipal Accounting Officer | Sell | 610 | 73K USD |
| 15 Oct 2026 | CAGNONI PABLO JPresident, Global Head of R&D | Sell | 2,642 | 298K USD |
| 15 Sep 2026 | CAGNONI PABLO JPresident, Global Head of R&D | Sell | 23,218 | 2.8M USD |
| 19 Aug 2026 | CAGNONI PABLO JPresident, Global Head of R&D | Sell | 10,801 | 1.4M USD |
| 12 Aug 2026 | CAGNONI PABLO JPresident, Global Head of R&D | Sell | 10,803 | 1.3M USD |
| Sold | 5 open-market sales | 48,074 | $5.82M |
8 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 15 Oct 2026 | CAGNONI PABLO JPresident, Global Head of R&D | Option exercise | 2,642 | 174K USD |
| 01 Oct 2026 | Heeson LeeEVP, Head of Incyte Intl | Tax withheld | 463 | 54K USD |
| 30 Sep 2026 | Clancy Paul JDirector | Award | 203 | 25K USD |
| 30 Sep 2026 | HARRIGAN EDMUNDDirector | Award | 206 | 25K USD |
| 30 Sep 2026 | BAKER BROS. ADVISORS LPDirector | Award | 644 | |
| 22 Sep 2026 | Gardner David HEVP, Chief Strategy Officer | Tax withheld | 920 | 117K USD |
| 15 Sep 2026 | CAGNONI PABLO JPresident, Global Head of R&D | Option exercise | 23,218 | 1.5M USD |
| 25 Aug 2026 | Basi Ramitpal KEVP, Human Resources | Tax withheld | 504 | 65K USD |
Which funds hold Incyte (INCY)?
1 of the 45 institutional funds we track reported a Incyte position for the quarter ended 30 Sep 2026 — a combined 17.6M USD; the latest of those filings landed 06 Nov 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Fisher Asset Management | Held (±25%) | 145,442 | 17.6M USD | +6.1% |
Have members of Congress traded Incyte (INCY)?
The most recent congressional trade disclosed in Incyte is a sale by Robert P. Bresnahan, Jr. (house, PA), dated 15 May 2025.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 15 May 2025 | Robert P. Bresnahan, Jr.house · Republican–PA | Sale | 1K USD–15K USD | 16 days |
| 06 Mar 2023 | Daniel S. Goldmanhouse · Democrat–NY | Sale | 1K USD–15K USD | 42 days |
What has been filed or recorded for Incyte (INCY)?
The filings we hold for Incyte, newest first: 7 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 14 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 14 Oct 2026 | Fails to deliver | Shares failed to deliver | 6 shares | 652 USD notional · <0.001% of shares out |
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 10 shares | 1K USD notional · <0.001% of shares out |
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 26,117 shares | 2.9M USD notional · 0.013% of shares out |
| 08 Oct 2026 | Fails to deliver | Shares failed to deliver | 109 shares | 12K USD notional · <0.001% of shares out |
| 06 Oct 2026 | Fails to deliver | Shares failed to deliver | 7,640 shares | 872K USD notional · 0.004% of shares out |
| 05 Oct 2026 | Fails to deliver | Shares failed to deliver | 1,540 shares | 178K USD notional · 0.001% of shares out |
| 02 Oct 2026 | Fails to deliver | Shares failed to deliver | 1,600 shares | 187K USD notional · 0.001% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS −3.86 USD | |
| 30 Sep 2026 | Financials | Total assets | 7.3B USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 5.6B USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS 2.81 USD | |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 1.47 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 6.41 USD | |
| 31 Dec 2025 | Financials | Revenue | 5.1B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 1.3B USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 6.41 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 2.11 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 2.04 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 0.80 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS 0.15 USD |
What is Reddit saying about Incyte (INCY)?
Reddit mentioned INCY 1 times in the 30 days to 10 November 2026, in 1 of the communities we track. All of them were scored for sentiment: 100% read bullish, 0% bearish and 0% neither. Reddit data updated 10 November 2026.
30-day window, Method
How do Reddit mentions of Incyte (INCY) compare with its price?
Share ↗
Which subreddits are talking about Incyte (INCY)?
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/etfs | 100% | 1 | +0.08 |
What do people ask about Incyte (INCY)?
What did Incyte shares close at?121.88
Incyte closed at 121.88 USD on 9 Nov 2026, up 1.83% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Incyte’s market cap?24.8B
Incyte is worth 24.8B USD by market value as of 9 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Incyte’s P/E ratio?64.8
Incyte has a price-to-earnings ratio of 64.8, as of 9 Nov 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is Incyte’s revenue?5.1B
Incyte reported revenue of 5.1B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Incyte insiders bought or sold shares recently?5 sales
In the 90 days to 10 Nov 2026, Incyte insiders reported 5 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 19 Feb 2026, show no open-market purchase. A further 8 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own Incyte?1 of 45
1 of the 45 funds we track reported a Incyte position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported position was Fisher Asset Management. See Funds
Have members of Congress traded Incyte?2 trades
Yes. 2 trades in Incyte appear in the congressional disclosures we hold; the latest is a sale by Robert P. Bresnahan, Jr. (House, PA) dated 15 May 2025, filed 31 May 2025. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did Incyte last report earnings?−3.86
Incyte last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −3.86 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Incyte?0 mentions
Incyte was mentioned 0 times in the last 7 days across the finance subreddits we track, and 1 times over the trailing 30 days. Of the 1 mentions scored for sentiment, 100% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- Wikimedia CommonsPortraits via Wikimedia Commons. Robert P. Bresnahan, Jr.: House Creative Services, Public domain; Daniel S. Goldman: US House, Public domain.
- House disclosuresU.S. House of Representatives financial disclosures
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings